Company Filing History:
Years Active: 1995-1997
Title: The Innovations of Erik Christensson
Introduction
Erik Christensson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of drug addiction. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Christensson's latest patents focus on the use of diphenylbutyl-piperazinecarboxamides in the treatment of withdrawal syndrome resulting from addiction to non-opiate type drugs. The inventions aim to relieve or prevent withdrawal symptoms and suppress dependence on these drugs. One of the key compounds he has worked with is 4-[4,4-bis(4-fluorophenyl)butyl]-N-ethyl-1-piperazine-carboxamide, known as amperozide.
Career Highlights
Throughout his career, Erik Christensson has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Kabi Pharmacia AB. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
One of his notable collaborators is Anders K Bjork, with whom he has worked on various projects related to his patents.
Conclusion
Erik Christensson's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing critical health issues. His work continues to pave the way for advancements in the treatment of drug addiction.